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Previewsaxonal injury and do not contribute to
the clearance of degenerated axons
(Doherty et al., 2009). This is in contrast
to mammalian astrocytes, which respond
to injury by increasing expression of
GFAP, exhibiting hypertrophy, and con-
tributing to the formation of glial scars.
These differences reflect independent
specialization of glia in different species.
In particular, mouse astrocytes have
been broadly classified as fibrous and
protoplasmic, while human astrocytes
as interlaminar, protoplasmic, polarized,
and fibrous, and evidence for further
regional specification of mammalian as-
trocytes is emerging (Molofsky et al.,
2014). The studies reported here involved
exclusive analysis of astrocytes in the
larval nerve cord; much less is known
about the properties and potential diversi-
fication of astrocytes in the Drosophila
brain.
Astrocytes are thought to participate in
a multitude of crucial events in the CNS,
from neurotransmitter and ion homeosta-
sis to vascular control and tissue repair.
And yet, a detailed understanding of
how they accomplish such diverse tasks
has remained elusive. Unfortunately,
astrocytes maintained in vitro exhibit
properties distinct from their counterparts
in the intact CNS (Cahoy et al., 2008), and
their complex structure presents signifi-cant challenges for localizing proteins of
interest and monitoring physiological
changes at sites of interaction with other
cells. Although the development of new
transgenic mouse lines has increased
our ability tomanipulate astrocytes in vivo,
specificity remains a problem due to the
similar genes expressed by radial glial
cells and astrocytes. Moreover, the need
to generate mice that carry multiple trans-
genes slows the pace of discovery and
places constraints on what manipulations
can be performed. As these studies by
Stork et al. (2014) demonstrate, the iden-
tification of a glial cell inDrosophila, which
exhibits many key features of astrocytes
in the mammalian CNS, has the potential
to rapidly expand our knowledge of the
functions performed by these cells under
different physiological and pathological
conditions and uncover the molecular
underpinnings of their diverse behaviors.REFERENCES
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ATP-gated P2X receptors are widely expressed in the nervous system, but their physiological roles are not
fully understood. New insights from Pougnet et al. (2014) in this issue of Neuron show that postsynaptic
P2X receptors may be activated by ATP released from astrocytes and function to downregulate synaptic
AMPA receptors in hippocampal neurons.Over 40 years ago, Geoffrey Burnstock
proposed the existence of purinergic
nerves that released ATP (Burnstock,1972). Although initially met with consid-
erable skepticism, there is now over-
whelming evidence that ATP is widelyused as a signaling molecule in the
body, including in the brain (Khakh and
Burnstock, 2009). ATP functions as a83, July 16, 2014 ª2014 Elsevier Inc. 257
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Previewsneurotransmitter and as a neuromodula-
tor by activating plasma membrane iono-
tropic P2X receptors and metabotropic
P2Y receptors. The P2X receptor family
belongs to the superfamily of neurotrans-
mitter-gated ion channels that includes
ionotropic glutamate and cys-loop recep-
tor families, but P2X receptors are
structurally (Kawate et al., 2009) and func-
tionally distinct in several important ways
(Khakh and North, 2012). Cationic P2X
receptors are assembled from three
subunits with just two transmembrane
domains per subunit, and the family com-
prises seven subunits (P2X1 to P2X7), six
homomeric receptors, and several het-
eromeric assemblies. Of these, P2X2
and P2X4 are widely expressed in the
brain (Collo et al., 1996), but in relation
to other neurotransmitter-gated ion chan-
nels, we still know very little about their
physiological roles. From this perspec-
tive, the work by Pougnet et al. (2014)
markedly extends our understanding of
the diversity of mechanisms utilized by
P2X receptors to regulate neurons by
revealing slow neuromodulatory func-
tions of ATP rather than fast actions that
are usually assumed and frequently
ascribed to neurotransmitter-gated ion
channels.
Early work showed that P2X receptors
mediate sparse fast synaptic transmis-
sion in some brain nuclei (Edwards et al.,
1992), but subsequent studies over
several years failed to identify widespread
fast ATP synaptic transmission at brain
neuroneuronal synapses (Khakh and
North, 2012). P2X receptors are also pre-
sent in presynaptic nerve terminals,
where their activation increases neuro-
transmitter release probability (Gu and
MacDermott, 1997; Khakh and Hender-
son, 1998), but the physiological settings
under which this occurs in the brain
are still unclear. Other pharmacological
studies have suggested that P2X recep-
tors may be involved in synaptic plasticity
(Pankratov et al., 2009), but definitive
evidence has been lacking because of
the paucity of selective antagonists with
which to explore roles for distinct P2X re-
ceptors. In addition to these findings, it
was recognized that P2X2 and P2X4
receptors were localized to dendrites,
where they were situated at the edges of
the postsynaptic density (PSD) and thus
distanced from synaptically activated258 Neuron 83, July 16, 2014 ª2014 ElsevierAMPA receptors located within PSDs
(Rubio and Soto, 2001). These high-reso-
lution immunogold electron microscopy
studies were extended using single
P2X2 receptor imaging on dendrites using
quantum dots. Here, P2X2 channels
sampled the dendritic surface at
0.01 mm2/s but failed to enter the PSD
and did not mediate fast synaptic trans-
mission (Richler et al., 2011). The current
study of Pougnet et al. (2014) starts with
these findings as a back story and simply
asks, what happens to excitatory synaptic
transmission when postsynaptic P2X re-
ceptors are activated on hippocampal
neurons? The experiments utilize several
complementary approaches, including
hippocampal cultures, Xenopus oocytes,
acute hippocampal slices, biochemistry,
and high-resolution imaging to address
this question. The new insights are sum-
marized below.
The core observations are reported in
Figures 1 and 7 of Pougnet et al. (2014).
The authors started their studies by
applying ATP for 1 min to hippocampal
neurons in culture and analyzed minia-
ture excitatory postsynaptic currents
(mEPSCs) mediated by AMPA receptors
over the next 30 min. They found that
ATP reliably decreased the amplitude of
mEPCSs in the majority of neurons over
a time course of 20–30 min. However,
ATP did not change the frequency of
mEPSCs, which argues against a presyn-
aptic effect. In these settings, Pougnet
et al. (2014) argued against a potential
role for postsynaptic metabotropic ATP
receptors and argued for the presence
of P2X receptors in hippocampal neurons.
The key observation is that brief applica-
tions of ATP caused enduring slow de-
creases in mEPSC amplitudes over tens
of minutes. Interestingly, a pioneering
study by the Bains lab had previously re-
ported a related response to ATP medi-
ated by P2X receptors in magnocellular
neurosecretory cells of the paraventricu-
lar nucleus (Gordon et al., 2005). In
that study, responses mediated by exog-
enous ATP were mimicked by ATP
released endogenously from astrocytes
in response to norepinephrine (NE) appli-
cations. In accord, Pougnet et al. (2014)
found that astrocytes in hippocampal cul-
tures expressed a1 adrenoceptors and
that NE mimicked the effects of exoge-
nous ATP, resulting in mEPSCs withInc.reduced amplitude. The effects of both
NE and ATP were blocked by PPADS,
an antagonist that blocks P2X receptors,
and the effects of NE were also blocked
by fluoroacetate (FAC), a metabolic toxin
that severely impairs (perhaps even de-
stroys) astrocyte functions. The basic
observations made with hippocampal
cultures and mEPSCs were reproduced
when field excitatory postsynaptic poten-
tials (fEPSPs) were measured in the CA1
region of hippocampal slices; ATP and
NE decreased fEPSP slopes in a manner
that was blocked by PPADS and FAC.
Taken together, these data suggest that
NE activation of adrenoceptors on astro-
cytes released substantial amounts of
ATP that in turn activated postsynaptic
P2X receptors, leading to a decrease
in mEPSC amplitudes (in culture) and
decreased fEPSP slope (in slices).
Next, Pougnet et al. (2014) performed a
series of functional and biochemical ex-
periments with heterologously expressed
P2X2 or P2X4 receptors together with
GluA1/A2 heteromeric and GluA1 homo-
meric AMPA receptors. These data show
that P2X receptor activation caused
Ca2+-dependent reduction in AMPA re-
ceptor-mediated responses even within
highly reduced systems such as Xenopus
oocytes. However, in oocytes the effect
of ATP occurred within minutes and
recovered slowly over tens of minutes.
The reduction of AMPA receptor-medi-
ated electrophysiological responses was
mirrored by a reduction in GluA1 and
GluA2 subunits on the cell surface of oo-
cytes. The mechanism proposed involves
loss of GluA1 and GluA2 receptors from
the surface with a presumed concomitant
increase in their clathrin-mediated endo-
cytosis. In this scenario, the initial trigger
for endocytosis is ATP-evoked Ca2+ entry
via P2X receptors.
The next section of the paper explored
the aforementioned mechanisms within
cultured hippocampal neurons express-
ing fluorescent protein-tagged GluA1
and GluA2 receptors with and without
P2X2 receptors. The use of pH-sensitive
pHluorin tags on the AMPA receptor sub-
units allowed Pougnet et al. (2014) to
monitor their expression on the surface
of neuronal dendrites; they found that
ATP activation of P2X2 receptors caused
the dynamin-dependent loss of cell-sur-
face dendritic AMPA receptors, which
Neuron
Previewswas in accord with their expectations
from oocyte studies. These data were
bolstered with experiments that imaged
natively expressed AMPA receptor sub-
units within hippocampal neurons before
and after ATP applications. Here, the
use of direct stochastic optical recon-
struction microscopy (dSTORM) showed
that ATP applications caused the loss
of GluA2 receptors from synapses. The
final section of the paper explored
whether ATP can cause synaptic depres-
sion of AMPA receptor-mediated fEPSPs
in acute slices through a mechanism in-
volving P2X receptors. The data suggest
that this did occur and that the mecha-
nisms underlying the ATP effect were
distinct from those that underlie long-
term depression (LTD), because the ATP
effect was not occluded by LTD. Pougnet
et al. (2014) provided pharmacological
evidence to show that the ATP-evoked
reduction in fEPSP slope involved phos-
phatase or Ca2+/calmodulin-dependent
protein kinase and that the same mecha-
nisms are involved in the reduction
of AMPA receptor currents in Xenopus
oocytes following activation of P2X2
receptors.
In summary, the paper by Pougnet et al.
(2014) shows that applications of ATP and
NE (to evoke endogenous ATP release)
reduced mEPSC amplitudes in hippo-
campal cultures, that activation of P2X2
receptors coexpressed with AMPA re-
ceptor subunits resulted in the reduction
of AMPA responses in Xenopus oocytes,
and that ATP applications caused a
reduction in fEPSPs within hippocampal
slices. As such, the paper raises the
intriguing possibility that endogenous
signaling by P2X receptors may be trig-
gered by ATP release from astrocytes,
and perhaps other cells such asmicroglia,
rather than ATP release from neurons. If
so, this may explain the lack of evidence
for fast ATP synaptic transmission and
would be in accord with the location of
P2X receptors outside the PSD (Rubio
and Soto, 2001). In this view, ATP P2X re-ceptors would serve neuromodulatory
roles and would perhaps only be engaged
under circumstances when astrocytes
release ATP.
The new findings by Pougnet et al.
(2014) set the stage for additional studies
to fully elucidate the modulation of gluta-
matergic transmission by P2X signaling.
It needs to be demonstrated directly that
ATP is released from astrocytes, and
under what physiological stimuli this
occurs. What precisely is the mechanistic
link between adrenoceptor activation and
ATP release? Does NE application to
astrocytes trigger P2X receptor-mediated
currents in hippocampal neurons? Which
type of adrenoceptor mediates these NE
responses? Do mEPSCs decrease in
amplitude in slices following ATP and NE
applications? What is the timescale,
magnitude, and relevance of the resultant
modulation? To that end, the biophysical
and pharmacological properties of the
P2X receptors in situ should be further
investigated. For instance, a role for
Ca2+ entry through P2X receptors in the
mediation of this response could be
explored with whole-cell voltage-clamp
recordings, where neurons could be dia-
lyzed with known concentrations of fast
and slow organic Ca2+ buffers with known
Ca2+ affinities. Exploiting the availability of
the well-characterized P2X2 and P2X4
knockout mice would strengthen the
case that this form of neuromodulation re-
lies exclusively on the ionotropic signaling
cascade the authors propose. More
generally, NE-evoked ATP release from
astrocytes results in reduced fEPSPs in
the hippocampus but increased synaptic
efficacy in the paraventricular nucleus
(Gordon et al., 2005). Are these differ-
ences due to the differential expression
of postsynaptic P2X receptors, down-
stream signaling, or the spatiotemporal
profile of the Ca2+ signal?
The intriguing implication of the current
work by Pougnet et al. (2014) is that
it may offer a clue for the neuronal
microcircuit effects that begin to occurNeuronseveral seconds after startle and arousal
responses in vivo, which recent beauti-
ful studies show are accompanied by
widespread NE-mediated Ca2+ signal-
ing in cortical astrocytes (Ding et al.,
2013; Paukert et al., 2014). If so,
neuronal P2X receptors may contribute
to norepinephrine regulation of startle,
arousal and related behaviors. All
together, the current study by Pougnet
et al. (2014) raises many questions for
future exploration.
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